Navigation Links
Scottish Scientists Lead This Year's Life Science Discoveries

CHICAGO, April 23, 2013 /PRNewswire/ -- Since January, Scotland has announced significant progress on several major life science discoveries slated to treat life-threatening diseases such as cancer, HIV and leukemia.

Scotland offers the UK's fastest R&D approval times and already ranks as the leading UK region for R&D investment, according to data from Ernst & Young. With industry challenges on the rise, Scotland continues to rely on its renowned R&D capabilities to generate sector growth.

To showcase their latest discoveries, 20 of Scotland's leading life science companies and research organizations are accompanying Scottish Development International, the country's economic development agency, at the 2013 BIO International Convention, April 22-25.

"Scotland continues to attract major investments from some of the world's leading life sciences companies including GlaxoSmithKline and LifeScan, further strengthening Scotland's position as a key cluster for life sciences innovation," notes Danny Cusick , President, Americas, of Scottish Development International.

Today, Scotland's BioOutsource, a global leader in the biological analysis of biosimilar molecules for the biopharmaceutical industry, announced its first facility opening in the U.S. To be based in Cambridge, Massachusetts the company believes the expansion will link Scotland's strong life science services to Boston's growing venture capital landscape.

In February, the University of Dundee and incubator campus, BioCity Scotland, won a project worth $128 million to discover new drug treatments—marking the biggest investment of its kind in Scotland from the European Innovative Medicines Initiative.

One month later, Dundee Cancer Center announced a new way to kill cancer cells in people with one of the most common forms of leukemia. Another Scottish company transforming the future treatment of cancer is VIRTTU, the first company allowed by the FDA to trial an oncolytic therapy in children, who has announced plans to assist in an upcoming pediatric brain tumor trial led by Cincinnati Children's Hospital.

Other Scottish organizations making developments include the University of Aberdeen, which was awarded $2 million in funding this February to research anti-cancer drugs utilizing shark immune system research and The University of Edinburgh, which received $26 million this month to research regenerative medicine for incurable conditions.

Scotland's recent R&D achievements have occurred alongside major company growth as well. Edinburgh BioQuarter, part of Europe's fastest-growing academic medical center, grew by more than a third in January alone thanks to new research tenants. Just this month, U.S. medical device company Daktari Diagnostics Inc. announced their decision to invest in Scotland to produce its latest HIV blood monitoring technology.

"Scotland's life science legacy boasts innovations such as the pioneering of stem-cell treatments to cure blindness and groundbreaking work to eradicate disease-carrying tsetse flies," says Cusick. "With this reputation for excellence, we feel confident that our recent R&D announcements will spur positive investment."

Home to 650+ life sciences organizations and more than 32,000 industry employees, Scotland seeks to target additional partnership and investment opportunities from North America to bolster their rapidly growing industry.

Media Contact: Rebecca Gehman ,, 973-800-3306

Notes to Editors:

Scottish Development International (SDI) is a partnership between the Scottish Government, Scottish Enterprise and Highlands and Islands Enterprise. SDI helps overseas businesses tap into Scotland's key strengths in knowledge, high level skills, technology and innovation. SDI also works to help Scottish companies do more business overseas and to promote Scotland as a good place to live and work. Its work is guided by the Scottish Government's strategy for economic development in Scotland.

SOURCE Scottish Development International
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
2. Scientists Find Way to Fast-Track Production of Stem Cells that Show Promise in Treating AMD
3. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
4. Highly lethal Ebola virus has diagnostic Achilles heel for biothreat detection, scientists say
5. NineSigma Announces Winners in $25,000 Sustainable Packaging Challenge in Conjunction With Scientists Without Borders and Partners
6. Research Team led by JCVI Scientists Uncover More Complexity and Detail in Southern African Genomic Diversity
7. Dr. Ali S. Faqi and Leading Scientists Author Ground-Breaking Toxicology Book from Elsevier
8. Scientists discover molecule that does double duty in stopping asthma attacks
9. Scientists Warn of Long Term Consequences of Budget Sequestration: BioInformatics LLC Report
10. UC Santa Barbara scientists develop a whole new way of harvesting energy from the sun
11. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), led ... also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. ... members have embraced this type of racing and several new model aviation pilots have ...
Breaking Biology Technology:
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/17/2015)... 2015 Paris , ... --> Paris , qui s,est tenu ... le leader de l,innovation biométrique, a inventé le premier ... empreintes sur la même surface de balayage. Jusqu,ici, deux ... pour les empreintes digitales. Désormais, un seul scanner est ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
Breaking Biology News(10 mins):